It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Acanthamoeba, a genus that contains at least 24 species of free-living protozoa, is ubiquitous in nature. Successful treatment of Acanthamoeba infections is always very difficult and not always effective. More effective drugs must be developed, and medicinal plants may have a pivotal part in the future of drug discovery. Our research focused on investigating the in vitro anti- acanthamoebic potential of Leea indica and its constituent gallic acid in different concentrations. Water and butanol fractions exhibited significant amoebicidal activity against trophozoites and cysts. Gallic acid (100 µg/mL) revealed 83% inhibition of trophozoites and 69% inhibition of cysts. The butanol fraction induced apoptosis in trophozoites, which was observed using tunnel assay. The cytotoxicity of the fractions and gallic acid was investigated against MRC-5 and no adverse effects were observed. Gallic acid was successfully loaded within poly (D,L-lactide-co-glycolide) (PLGA) nanoparticles with 82.86% encapsulation efficiency, while gallic acid showed 98.24% in vitro release at 48 hours. Moreover, the gallic acid encapsulated in the PLGA nanoparticles exhibited 90% inhibition against trophozoites. In addition, gallic acid encapsulated nanoparticles showed reduced cytotoxicity towards MRC-5 compared to gallic acid, which evidenced that natural product nanoencapsulation in polymeric nanoparticles could play an important role in the delivery of natural products.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 University of Malaya, Department of Medical Microbiology, Faculty of Medicine, Kuala Lumpur, Malaysia (GRID:grid.10347.31) (ISNI:0000 0001 2308 5949); University of Malaya, Department of Parasitology, Faculty of Medicine, Kuala Lumpur, Malaysia (GRID:grid.10347.31) (ISNI:0000 0001 2308 5949)
2 Imam Abdulrahman Bin Faisal University, Department of Nano-Medicine Research, Institute for Research and Medical Consultations (IRMC), Dammam, Saudi Arabia (GRID:grid.411975.f) (ISNI:0000 0004 0607 035X)
3 University of Aveiro, Department of Medical Sciences & CICECO-Aveiro Institute of Materials, Aveiro, Portugal (GRID:grid.7311.4) (ISNI:0000000123236065)
4 University of Malaya, Department of Parasitology, Faculty of Medicine, Kuala Lumpur, Malaysia (GRID:grid.10347.31) (ISNI:0000 0001 2308 5949)
5 University of Malaya, Department of Medical Microbiology, Faculty of Medicine, Kuala Lumpur, Malaysia (GRID:grid.10347.31) (ISNI:0000 0001 2308 5949)
6 MAHSA University, Saujana Putra Campus, Faculty of Medicine, Selangor, Malaysia (GRID:grid.459705.a) (ISNI:0000 0004 0366 8575)
7 Nottingham University Malaysia Campus, 43500 Semenyih, Selangor, School of Pharmacy, Kuala Lumpur, Malaysia (GRID:grid.440435.2)
8 University of Malaya, Department of Parasitology, Faculty of Medicine, Kuala Lumpur, Malaysia (GRID:grid.10347.31) (ISNI:0000 0001 2308 5949); Walailak University, School of Allied Health Sciences, Southeast Asia Water Team (SEA Water Team), and World Union for Herbal Drug Discovery (WUHeDD), Nakhon Si, Thailand (GRID:grid.412867.e) (ISNI:0000 0001 0043 6347); Walailak University, Research Excellence Center for Innovation and Health Products (RECIHP), Nakhon Si, Thailand (GRID:grid.412867.e) (ISNI:0000 0001 0043 6347)